Targeting the Gut–Liver Axis in Cirrhosis: Antibiotics and Non-Selective β-Blockers

Probiotic as a Novel Treatment Strategy Against Liver Disease

(2013) Abbas Ali Imani Fooladi et al.   Hepatitis Monthly

Microbiota-liver axis in hepatic disease

(2013) Benoit Chassaing et al.   HEPATOLOGY

The burden of liver disease in Europe: A review of available epidemiological data

(2013) Martin Blachier et al.   JOURNAL OF HEPATOLOGY

Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile

(2013) Els van Nood et al.   NEW ENGLAND JOURNAL OF MEDICINE

Meta-analysis: banding ligation and medical interventions for the prevention of rebleeding from oesophageal varices

(2012) M. Thiele et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Development of Ascites in Compensated Cirrhosis With Severe Portal Hypertension Treated With β-Blockers

(2012) Virginia Hernández-Gea et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4

(2012) Dianne H. Dapito et al.   CANCER CELL

Effect of Long-term Propranolol Treatment on Hepatocellular Carcinoma Incidence in Patients with HCV-Associated Cirrhosis

(2012) G. Nkontchou et al.   Cancer Prevention Research

Rifaximin Improves Systemic Hemodynamics and Renal Function in Patients With Alcohol-Related Cirrhosis and Ascites

(2012) Georgios N. Kalambokis et al.   Clinical Gastroenterology and Hepatology

Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome

(2012) Anne Vrieze et al.   GASTROENTEROLOGY

The window hypothesis: haemodynamic and non-haemodynamic effects of β-blockers improve survival of patients with cirrhosis during a window in the disease: Figure 1

(2012) Aleksander Krag et al.   GUT

New therapeutic paradigm for patients with cirrhosis

(2012) Emmanuel A. Tsochatzis et al.   HEPATOLOGY

Interaction between intestinal dendritic cells and bacteria translocated from the gut in rats with cirrhosis

(2012) Leticia Muñoz et al.   HEPATOLOGY

Second infections independently increase mortality in hospitalized patients With cirrhosis: the north american consortium for the study of end-stage liver disease (NACSELD) experience

(2012) Jasmohan S. Bajaj et al.   HEPATOLOGY

Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis

(2012) Jiannis Vlachogiannakos et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease

(2012) Derrick E. Fouts et al.   JOURNAL OF HEPATOLOGY

Acute-on chronic liver failure

(2012) Rajiv Jalan et al.   JOURNAL OF HEPATOLOGY

Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications

(2012) Pablo Bellot et al.   LIVER INTERNATIONAL

Expression and Functional Coupling of Liver ß2-Adrenoceptors in the Human Hepatocellular Carcinoma

(2012) Woubet T. Kassahun et al.   PHARMACOLOGY

Gut-Liver Axis and Sensing Microbes

(2011) Gyongyi Szabo et al.   DIGESTIVE DISEASES

Altered intestinal tight junctions’ expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability

(2011) Stelios F. Assimakopoulos et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Characterization of fecal microbial communities in patients with liver cirrhosis

(2011) Yanfei Chen et al.   HEPATOLOGY

Rifaximin reduces endotoxemia and improves liver function and disease severity in patients with decompensated cirrhosis

(2011) Georgios N. Kalambokis et al.   HEPATOLOGY

Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining Prognosis

(2010) Vasiliki Arvaniti et al.   GASTROENTEROLOGY

Splanchnic sympathectomy prevents translocation and spreading of E coli but not S aureus in liver cirrhosis

(2010) M. Worlicek et al.   GUT

Does cardiac dysfunction explain deleterious effects of beta-blockers in cirrhosis and refractory ascites?

(2010) Aleksander Krag et al.   HEPATOLOGY

Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis

(2010) Pablo Bellot et al.   HEPATOLOGY

Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites

(2010) Thomas Sersté et al.   HEPATOLOGY

The role of intestinal endotoxin in liver injury: A long and evolving history

(2010) James P. Nolan   HEPATOLOGY

EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis

(2010)   JOURNAL OF HEPATOLOGY

Rifaximin Treatment in Hepatic Encephalopathy

(2010) Nathan M. Bass et al.   NEW ENGLAND JOURNAL OF MEDICINE

Management of Varices and Variceal Hemorrhage in Cirrhosis

(2010) Guadalupe Garcia-Tsao et al.   NEW ENGLAND JOURNAL OF MEDICINE

Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis

(2009) J. VLACHOGIANNAKOS et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Oral Propranolol Decreases Intestinal Permeability in Patients With Cirrhosis: Another Protective Mechanism Against Bleeding?

(2009) Marco Senzolo et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Intestinal Permeability in Cirrhotic Patients With and Without Spontaneous Bacterial Peritonitis: Is the Ring Closed?

(2009) Emidio Scarpellini et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Association Between Small Intestinal Bacterial Overgrowth and Peripheral Bacterial DNA in Cirrhotic Patients

(2009) Dae Won Jun et al.   DIGESTIVE DISEASES AND SCIENCES

Norfloxacin Modulates the Inflammatory Response and Directly Affects Neutrophils in Patients With Decompensated Cirrhosis

(2009) Pedro Zapater et al.   GASTROENTEROLOGY

Secondary Prophylaxis of Hepatic Encephalopathy: An Open-Label Randomized Controlled Trial of Lactulose Versus Placebo

(2009) Barjesh Chander Sharma et al.   GASTROENTEROLOGY

Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites

(2009) A Krag et al.   GUT

Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis

(2009) Guadalupe Garcia-Tsao et al.   HEPATOLOGY

Norfloxacin treatment for clinically significant portal hypertension: results of a randomised double-blind placebo-controlled crossover trial

(2009) William Kemp et al.   LIVER INTERNATIONAL

β-Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis

(2009) Marco Senzolo et al.   LIVER INTERNATIONAL

Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion

(2009) Borhane Annabi et al.   PHARMACOLOGICAL RESEARCH

Serum and ascitic fluid bacterial DNA: A new independent prognostic factor in noninfected patients with cirrhosis

(2008) Pedro Zapater et al.   HEPATOLOGY

Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via β-adrenoceptor-dependent transactivation of extracellular signal-regulated kinase/cyclooxygenase-2 pathway

(2008) Xuan Liu et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Liver cirrhosis

(2008) Detlef Schuppan et al.   LANCET

Microbial endocrinology: how stress influences susceptibility to infection

(2008) Primrose P.E. Freestone et al.   TRENDS IN MICROBIOLOGY